# L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors

> **NCT00003430** · PHASE1 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 40 (estimated)

## Conditions studied

- Head and Neck Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** L-778,123

## Key facts

- **NCT ID:** NCT00003430
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-04
- **Primary completion:** 2000-04
- **Final completion:** 2000-04
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2013-06-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003430, "L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*